ADUS vs. AHCO, AMED, EHAB, LHCG, OPCH, IRWD, SILK, XNCR, SKIN, and VCYT
Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include AdaptHealth (AHCO), Amedisys (AMED), Enhabit (EHAB), LHC Group (LHCG), Option Care Health (OPCH), Ironwood Pharmaceuticals (IRWD), Silk Road Medical (SILK), Xencor (XNCR), Beauty Health (SKIN), and Veracyte (VCYT). These companies are all part of the "medical" sector.
Addus HomeCare vs.
Addus HomeCare (NASDAQ:ADUS) and AdaptHealth (NASDAQ:AHCO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, valuation, profitability, risk, dividends, earnings and analyst recommendations.
97.4% of Addus HomeCare shares are owned by institutional investors. Comparatively, 86.3% of AdaptHealth shares are owned by institutional investors. 4.5% of Addus HomeCare shares are owned by insiders. Comparatively, 17.3% of AdaptHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Addus HomeCare presently has a consensus price target of $113.00, suggesting a potential upside of 8.24%. AdaptHealth has a consensus price target of $25.33, suggesting a potential upside of 91.19%. Given AdaptHealth's higher possible upside, analysts plainly believe AdaptHealth is more favorable than Addus HomeCare.
Addus HomeCare received 206 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 66.51% of users gave Addus HomeCare an outperform vote while only 63.06% of users gave AdaptHealth an outperform vote.
AdaptHealth has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.
In the previous week, Addus HomeCare had 2 more articles in the media than AdaptHealth. MarketBeat recorded 8 mentions for Addus HomeCare and 6 mentions for AdaptHealth. Addus HomeCare's average media sentiment score of 0.57 beat AdaptHealth's score of 0.49 indicating that Addus HomeCare is being referred to more favorably in the media.
Addus HomeCare has a net margin of 4.84% compared to AdaptHealth's net margin of 2.33%. Addus HomeCare's return on equity of 8.58% beat AdaptHealth's return on equity.
Addus HomeCare has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500.
Summary
Addus HomeCare beats AdaptHealth on 11 of the 16 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Addus HomeCare Competitors List